CU6 1.41% $6.46 clarity pharmaceuticals ltd

Ann: First patient dosed in Phase III prostate cancer trial, page-2

  1. 2,697 Posts.
    lightbulb Created with Sketch. 2821
    https://hotcopper.com.au/data/attachments/5839/5839181-db554524bae460badefd863df06f7d3e.jpg
    And it begins!
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.